These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28622390)

  • 41. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter.
    Iwamoto S; Withers DA; Handa K; Hakomori S
    Glycoconj J; 1999 Oct; 16(10):659-66. PubMed ID: 10972144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.
    Petak I; Danam RP; Tillman DM; Vernes R; Howell SR; Berczi L; Kopper L; Brent TP; Houghton JA
    Cell Death Differ; 2003 Feb; 10(2):211-7. PubMed ID: 12700649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.
    Song MH; Ha JC; Lee SM; Park YM; Lee SY
    Biochem Biophys Res Commun; 2011 May; 408(2):195-201. PubMed ID: 21338577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
    Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
    Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer.
    Mirandola L; J Cannon M; Cobos E; Bernardini G; Jenkins MR; Kast WM; Chiriva-Internati M
    Int Rev Immunol; 2011; 30(2-3):127-37. PubMed ID: 21557639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.
    Setiadi AF; Omilusik K; David MD; Seipp RP; Hartikainen J; Gopaul R; Choi KB; Jefferies WA
    Cancer Res; 2008 Dec; 68(23):9601-7. PubMed ID: 19047136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene.
    Daly T; Royal RE; Kershaw MH; Treisman J; Wang G; Li W; Herlyn D; Eshhar Z; Hwu P
    Cancer Gene Ther; 2000 Feb; 7(2):284-91. PubMed ID: 10770638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
    Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
    Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
    Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
    Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
    Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
    Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.
    Vo MC; Nguyen-Pham TN; Lee HJ; Jaya Lakshmi T; Yang S; Jung SH; Kim HJ; Lee JJ
    Oncotarget; 2017 Apr; 8(16):27252-27262. PubMed ID: 28460478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MHC class I-presented tumor antigens identified in ovarian cancer by immunoproteomic analysis are targets for T-cell responses against breast and ovarian cancer.
    Morse MA; Secord AA; Blackwell K; Hobeika AC; Sinnathamby G; Osada T; Hafner J; Philip M; Clay TM; Lyerly HK; Philip R
    Clin Cancer Res; 2011 May; 17(10):3408-19. PubMed ID: 21300761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
    Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
    Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.
    Foran E; Garrity-Park MM; Mureau C; Newell J; Smyrk TC; Limburg PJ; Egan LJ
    Mol Cancer Res; 2010 Apr; 8(4):471-81. PubMed ID: 20354000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
    Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.
    Ahluwalia A; Yan P; Hurteau JA; Bigsby RM; Jung SH; Huang TH; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):261-8. PubMed ID: 11531277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
    Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
    Liu Z; Wang LE; Wang L; Lu KH; Mills GB; Bondy ML; Wei Q
    Clin Cancer Res; 2005 Jul; 11(13):4968-76. PubMed ID: 16000597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.
    Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S
    Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.